Alzheimer’s Claims a New Victim every 7 Seconds and dementia had an estimated worldwide cost in 2010 of $604 billion
LOS ANGELES, CA September 21, 2011: GTX Corp (OTCQB: GTXO), a leader in customizable, miniaturized GPS Personal Location Services (PLS) solutions, announced today the FCC certification of the GPS Shoe and the delivery of the first 3,000 units to shoe partner Aetrex Worldwide, Inc. As millions of boomers are approaching 65 and in recognition of World Alzheimer's Day on September 21, 2011, GTX Corp is proud to announce the release of the world's first GPS tracking technology to be imbedded into comfort and wellness shoes for individuals afflicted with Alzheimer's disease and related dementia.
“This is a significant milestone for both Companies and while the $604 billion worldwide cost of dementia has become and will continue to be a significant fiscal challenge, the under $300 GPS enabled shoes will ease the enormous physical and emotional burden borne by Alzheimer’s victims, caregivers and their geographically distant family members,” states Patrick Bertagna CEO of GTX Corp and co inventor of the award winning, multi patent GPS Shoe.
"The GPS Shoe has the potential to be life saving, as well as life changing technology for those afflicted and their caregivers," says Andrew Carle, who has been internationally recognized for coining the term “Nana” Technologies for describing technology for older adults. Carle has served as an advisor to GTX Corp for the past 3 years and is additionally Director of the Program in Senior Housing Administration at George Mason University in Fairfax, VA. "The shoes also hold the potential to save governments hundreds of millions of dollars in search and rescue operations, as well in health care costs for those otherwise injured." The World Alzheimer Report 2010 provides the clearest, most comprehensive global picture yet of the economic impact of Alzheimer's disease and dementia.
Over five million Americans suffer from Alzheimer’s and without a cure; those numbers are expected to quadruple, to more than 20 million in the U.S. and 106 million worldwide. Statistics show 60% of those afflicted will wander and become lost and up to half of those lost who are not found within 24 hours may die, from dehydration, exposure, or injury. Because paranoia is a manifestation of the disease, many will remove objects placed upon them with which they are unfamiliar. However, habitual memory, which includes getting dressed, is the last type of memory retained in individuals with Alzheimer's. Affirming the placement of the miniaturized 2-way GPS technology in comfort and wellness shoes an efficient and useful monitoring solution for the estimated 15 million family and caregivers of people suffering from the disease.
The Aetrex GPS Shoes will be available for sale at www.aetrex.com, www.gpsshoe.com, www.foot.com and www.gtxcorp.com for an estimated retail price of $299 anticipated beginning in or around the second half of October.
About GTX Corp
GTX Corp® utilizes the latest in miniaturized, low power consumption technology and offers a robust 2 way GPS and cellular location platform that enables subscribers to track in real time the whereabouts of people, pets, or high valued assets through a complete end to end - customizable GPS/GPRS transceiver module, wireless connectivity gateway, Smartphone Apps, middleware, and viewing portal. For further information please visit:
www.gtxcorp.com | www.facebook.com/gtxcorp | www.twitter.com/gtxcorp | www.gtxo.irnewsroom.com
General / Licensing Information - info@gtxcorp.com
Investor Relations | ir@gtxcorp.com
Media | Suzy Ginsburg | (713) 334-2357 | suzy@gcomworks.com
About GLX - The Global Listing Exchange
The Global Online Investment Community - GLX provides interactive advertising, conference and event coordination, digital IR/PR, journalism, market intelligence, media/marketing, news dissemination, research, video production and ancillary specialty communications services to publicly traded companies worldwide.
+1 855 GLX INTL | +1 855 459 4685
No comments:
Post a Comment